NetworkNewsBreaks – PowerBank Corporation (NASDAQ: SUUN)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
189
NetworkNewsBreaks – PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Advances 5.7 MW North Main St Solar Project in New York Following CESIR Completion

Disseminated on behalf of PowerBank Corporation

PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103), a North American energy infrastructure developer and asset owner, announced that its 5.7 MW North Main St ground-mount solar project in upstate New York has completed its Coordinated Electric System Interconnection Review and will now advance to site permitting. The project is expected to qualify for New York’s Value of Distributed Energy Resources compensation mechanism with an estimated first-year average rate of US$0.0971/kWh. Once permitted and financed, construction will begin on the community solar initiative, which will deliver clean energy to the local grid while enabling renters, businesses and homeowners to subscribe for bill credits and savings. PowerBank, with over 100 MW of completed projects and a development pipeline exceeding 1 GW, said the project supports New York’s Climate Leadership and Community Protection Act goal of 6 GW of solar by 2025.

To learn more about PowerBank, please visit www.powerbankcorp.com .

This report contains forward-looking information. Please refer to https://ibn.fm/pSPnr for additional details.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://nnw.fm/SUUN

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

SolarBank Corp. (SUUN) Stock Research Links

SUUN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Stellar Elevates Leadership with Key Promotions to Drive Growth

Updated Category News Views 212

Stellar Strengthens Leadership Team for Future Success The new Executive Vice Presidents, Senior Vice President, and Vice Presidents will assume leadership roles this month. Stellar, an integrated design-build firm, proudly announces a strategic expansion of its leadership team, marking an important milestone in the company's ongoing growth and development. CEO Brian...

Continue Reading
Revolutionizing Fashion: Pixelz's Digital Twins Transform AI

Updated Category News Views 197

Transforming Fashion Content Creation Pixelz, a pioneering platform in fashion e-commerce content creation, has made headlines with its innovative approach to Artificial Intelligence (AI) featuring Digital Twins. This groundbreaking solution empowers brands to produce stunning, campaign-quality imagery rapidly and with creativity, thanks to a unique collaboration with...

Continue Reading
Alstom's First Half Results for Fiscal Year 2024/25 Unveiled

Updated Category News Views 212

Alstom's First Half Results Overview Alstom, a leading player in the transportation sector, recently shared significant updates regarding its performance in the first half of the fiscal year 2024/25. The presentation showcases their commitment to growth, innovation, and sustainability throughout the railway industry. Financial Highlights During this presentation, Alstom...

Continue Reading
Brooke Shields Leads 'Hearts of Heroes' Season 8

Updated Category News Views 10

A New Face Shines on 'Hearts of Heroes' Buckle up, folks! Brooke Shields is strapping in for the eighth season of 'Hearts of Heroes,' the award-winning show spotlighting everyday champions and first responders. Premiering on July 11, this series lands a spot in ABC's Weekend Adventure block, thrusting Shields into the limelight as she takes the baton from previous hosts...

Continue Reading
Cytokinetics' MYQORZO® Gains Approval for Hypertrophic Cardiomyopathy

Updated Category News Views 118

Cytokinetics' MYQORZO® Achieves NMPA Approval in China Cytokinetics, Incorporated (NASDAQ: CYTK) has exciting news—the approval of MYQORZO® (aficamten) by the China National Medical Products Administration (NMPA) for adults suffering from obstructive hypertrophic cardiomyopathy (oHCM). This milestone not only underscores the effectiveness of their innovative therapy...

Continue Reading